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INTRODUCTION
Autonomic dysreflexia (AD) is a life threatening condition of episodic vascular hypertension (often with bradycardia, i.e., slowed heart rate) that develops in most (~90%) people with a spinal cord injury (SCI) above thoracic spinal level T5. After high level SCI, loss of supraspinal control together with aberrant collateral sprouting and formation of new intraspinal synapses (i.e., synaptogenesis) causes spinal autonomic reflexes to become exaggerated [1] [2] [3] [4] . This postinjury maladaptive neural plasticity, involving sensory axons and propriospinal interneurons that connect multiple segments of the thoracic and upper lumbar spinal cord, progresses slowly over the course of several weeks or months post-injury. Prevention (e.g., regular bladder/bowel care) and anti-hypertensive medications are currently the best way to "manage" AD; however, there is no cure [5] . In this study, genetic and pharmacological tools are used to test the hypothesis that post-injury inhibition of reactive synaptogenesis will block the onset or reduce the severity of AD. After CNS injury, astroglia and macrophages secrete thrombospondins (TSP), a family of matricellular proteins that regulate cell-cell and cell-matrix interactions, most notably neurite growth and synaptogenesis [6, 7] . Eroglu et al. showed that astrocyte-derived TSPs cause synaptogenesis by binding to neuronal α2δ-1 receptors and that transgenic over expression of neuronal α2δ-1dramatically increases synaptogenesis [7] . TSP-4 is selectively increased in astrocytes surrounding injured spinal cord axons. Here with genetic tools, we predict that TSP-4 KO will block the onset or reduce the severity of AD, however the α2δ-1 over-expression will enhance the development of AD. Anti-epileptic/anti-neuropathic pain drugs gabapentin (Neurontin) and pregabalin (Lyrica) bind with α2δ-1 [8] thereby blocks TSP/α2δ-1 interactions as well as inhibits TSP-induced new synapse formation [7] . We hypothesize that inhibiting TSP binding to neuronal α2δ-1 with GBP will reduce the severity and frequency of AD by inhibiting maladaptive synaptogenesis after SCI. Our results indicated that mice carry an extra α2δ-1 gene developed more AD than WT littermates after T3 SCI. GBP s.c. injection inhibits AD development in WT BL6 mice. This study suggested that post-injury synapgenesis is an important mechanism underlining the development of AD post T3 SCI. 
KYWORDS

1) Major activities and Specific objectives:
We obtained α2δ-1 TG (129SVE background) and TSP null mice (C57BL/6 background) lines from Dr Eroglu (Duke) on Feb 7, 2014. In the August 2014 (1st) and Oct 2015 (repeat), we bred enough α2δ-1 TG and WT littermates for first objective: comparing the development of AD (frequency and/or severity) in α2δ-1 TG vs WT littermates after T3 SCI. And in the July 2015 (1 st ) and July 2016 (2 nd repeat), we bred enough TSP4 KO and WT littermates for the second objective: comparing the development of AD (frequency and/or severity) in TSP KO and WT littermates.
Surgery procedures: All animals were maintained in a pathogen-free environment before surgical implant of telemetry transmitters. Telemetry transmitters were implanted into each mouse as described previously [9] . Briefly, the PhysioTel telemetry system with PA-C10 telemetry transmitters (Data Sciences International) were implanted in anesthetized mice 3 days before SCI via a cannulation of the left common carotid artery (CCA) to monitor the blood pressure (BP) and heart rate (HR). The extra-vascular portion of the transmitter was placed into a subcutaneous pocket created on the lateral flank. The CCA was exposed through a midline incision on the neck, and the catheter of transmitter was introduced into the CCA through a small incision near the carotid bifurcation and advanced until the sensing region of the catheter was positioned in the aortic arch (8-9mmfrom the carotid bifurcation). Complete spinal cord transaction injuries were performed as described previously [10] . Briefly, using aseptic technique, a partial laminectomy was performed at vertebral level T3, after which the periosteum and dura mater were carefully opened. Using iridectomy scissors together with gentle aspiration, the spinal cord was cut, creating a clear separation between the rostral and caudal stumps of transected spinal cord. After injury, muscle and skin were sutured separately and then mice were injected with sterile saline (2 ml, s.c.) and placed individually into warmed HEPA filtered cages. Postoperative care included manual bladder expression 2/d and daily antibiotics for the first 7day post injury (dpi) (gentocin, 5mg/kg, s.c.). Dehydration was monitored daily and body weight and urinary pH was monitored weekly. All surgical procedures were approved by and performed in accordance with the Institutional Laboratory Animal Care and Use Committee at The Ohio State University.
Analysis of spontaneous AD: Dataquest data acquisition software (Data Sciences International) was used to acquire HR and BP data between 5 and 35 dpi at 5 s intervals with implanted telemetry transmitters. MATLAB software was used to create an algorithm that would detect episodes of spontaneous AD. The current automated program works similarly to the previous semi-automated method developed by Yi Zhang [9] , but incorporates the manual validation steps into the computer algorithm to improve objectivity and efficiency as described in details in previous annual report.
Colorectal distension and pinch to intentionally elicit AD: Colorectal distension and cutaneous pinch was used to elicit spinal autonomic reflexes as described previously [9] . The tips of Hartman hemostats were shielded with polyethylene tubing and then used to pinch the flank below the level of SCI just rostral to the hip joint. To ensure consistent pinch intensity and duration, the hemostat was closed to the first click in every trial for 30 s. Colorectal distension was accomplished using a 4-French, 60 mm balloon-tipped catheter (Swan-Ganz monitoring catheter model 116F4; Edwards Life Sciences). The catheter was inserted into the anus, positioning the balloon ~1.5 cm from the anal opening and then securing the catheter to the tail with surgical tape. After securing the catheter, animals were left alone to acclimate for at least 20 min. To elicit AD, the balloon was inflated with 0.3 ml of air for 1 min. Distention was maintained for 1 min and repeat stimulation occurred after a 30 min rest. Peak changes in BP and corresponding HR were obtained and then compared with baseline values.
2) Significant results or key outcomes
Automated detection of AD events was established use a MATLAB program and validated by comparing with the semi-automated techniques (data shown in previous annual report). With this automated detection method we can easily analyze continuous cardiovascular data (e.g., MBP and MHR) over 35 days for 16 mice (limited by the number of transmitter receiver) within hours (as compared to weeks or months with previous method). Overall, the automated program works similarly to the previous semi-automated method, but incorporates the manual validation steps into the computer algorithm to improve objectivity and efficiency.
Both a2d1 TG and WT littermates, which are on a 129 genetic background, did not develop late phase autonomic dysreflexia as described previously in WT C57BL/6J (B6) mice. Also, when compared with WT littermate control mice, the number of spontaneously occurring AD events increases significantly in a2d1 TG mice during the first week post-injury after T3 SCI ( Figure 1 ).
These data indicate genetically-encoded differences in mechanisms controlling autonomic dysfunction after SCI.
To determine whether it is possible to intentionally elicit AD in 129 mice, skin pinch or colorectal distension were used to elicit somatic or visceral-sympathetic reflexes below the level of injury. Such stimuli are potent induces of autonomic dysreflexia after high-level SCI.
Surprisingly, neither stimulus elicited AD in most (~80%) 129 mice ( Figure 2 ).
Previous data from our lab indicate that high-level SCI (e.g., T3 injuries) causes immune suppression, an effect that is linked to the development of aberrant autonomic reflexes in the isolated spinal cord below the level of injury [9] . Although we were unable to elicit AD in 129 mice, we next determined whether immune suppression develops in these mice after T3 SCI. The spleens of both a2d1 TG, and WT mice were isolated at 38 days post-injury and spleen weights were normalized to body weight. The data are consistent with our previous observations in C57BL/6 SCI mice, i.e., there is significant splenic atrophy after T3 SCI in both a2d1 TG and WT 129 animals [9] (Figure 3 ). From these data we conclude that post-injury plasticity in the autonomic circuitry responsible for AD and immune suppression can be mutually exclusive. To test the effect of TSP4 on post injury synaptogenesis and AD development, in July 2016, we repeated a previous experiment in which we analyzed AD development after T3 SCI in TSP4 KO and WT littermate control mice. The data indicate that there are no significant differences in AD development between TSP4KO and WT littermate control mice. Below, we report data from the first experiment ( Figure 4A ) and the repeat experiment ( Figure 4B ). Figure 4C combines the data from both independent studies. Note, that in both studies, WT mice showed an early peak of AD (second week post-injury); however, there were no significant differences between groups over time. Also, we noted interexperimental differences in the overall magnitude of AD events. Such differences are difficult to explain but we did note that there were age and sex differences between mice used in Exp 1 and Exp. 2 ( Figure 4D ). Such differences were unavoidable as mice were used as they became available from breeding pairs. Still, the average age of mice used in the first experiment was ~6 months while those in Exp. 2 were ~3 months. Also, 56% of mice in Exp. 1 were male while 50% of mice were male in Exp 2. Whether age and sex differences contribute to differences in the magnitude of early AD events is not known and is outside the scope of the funded studies.
To determine if TSP KO affects intentionally induced AD (iAD), a skin pinch or colorectal distension (CRD) stimulus was used to elicit a somatic or visceral-sympathetic reflex below the level of injury in TSP KO and WT littermates at 30dpi. These stimuli potently induce AD after high-level (T3) SCI. Data indicates that both stimuli elicit AD in both groups with similar level increase in BP with a corresponding decrease in HR ( Figure 5 ). Previous data from our lab indicate that high-level (T3) SCI causes splenic atrophy and immune suppression, an effect that is linked to the development of aberrant autonomic reflexes in the isolated spinal cord below the level of injury. Accordingly, we measured spleen weight in TSP4 KO and WT mice isolated at 30 dpi. Data show that there is no significant difference in spleen weights ( Figure 6 ). 
Figure 5. Colorectal distension (A, B) and cutaneous pinch (C, D) increase blood pressure (BP) and decrease heart rate (i.e., elicit AD) in both TSP4 KO and WT littermates.
Representative raw BP tracing, Mean artery blood pressure (MABP) and mean heart rate (MHR) changes are showed after 1min colon extension (A) and 30 seconds subcutaneous pinch (C) (red arrows indicates the beginning and ending of the stimulation). The accumulative data for MBP increase and MHR decrease after colorectal distension and cutaneoue pinch in WT and TSP KO mice are showed in B and D.
3) Other achievements.
Nothing to report.
Goal 2: Comparing AD events in GBP vs control group after T3 SCI. (70% completion)
1) Major activities and Specific objectives:
We tested whether high dose gabapentin (GBP) (200mg/kg) TID can reduce post-injury synaptogenesis and the frequency and/or severity of AD in Feb 2016.
2) Significant results or key outcomes
To test if high dose of gabapentin (GBP) inhibits the post injury synaptogenesis and the development of AD after T3 SCI, GBP (200mg/kg) or 100ul PBS was injected s.c. 3 times / day (TID) after T3 SCI for 4 weeks. Data in Figure 7 shows that GBP reduces the frequency of AD. To further test if GBP treatment has causes effect on T3 SCI-induced splenic atrophy and immune suppression, we measured spleen weight from GBP and PBS treated mice isolated at 30 dpi. Data show that high dose chronic GBP treatment significantly reduced spleen atrophy caused by T3 SCI (Figure 9 ). 
3) Other achievements.
Goal 3: Complete immunohistochemistry analysis for synaptogenesis of all animals. (30% completion)
1) Major activities and Specific objectives:
All mice (a2d1 TG vs WT; TSP4 KO vs WT, GBP 200mg/kg s.c. tid vs PBS), after recording ~30 days of BP and HR, were perfused as described previously [14] . In detail, mice were 
2) Significant results or key outcomes:
The preliminary results from 3 pairs of the SCI mice with GBP (200mg/kg s.c. tid) treatment vs PBS injection suggested GBP treatment did not reduce the excitatory synapse ( Figure 10 ) as we expected but increase the amount of inhibitory synapse ( Figure 11 ). Excitatory (VGlut2/Homer) and inhibitory (VGAT/Gephyrin) synaptic staining in two regions: T1-T3 (site above injury) and lower down at T4-T9 (sit below the injury). There is not any change in the excitatory synapses (although Homer itself was increased with GBP in both regions) ( Figure 10 ).
However, there was a dramatic increase in inhibitory synapses in both regions with GBP ( Figure  11 ). This was driven by up-regulation of both VGAT and gephyrin. GBP may improve sprouting of inhibitory neuron axons and that results in rewiring of inhibitory circuits. injured mice (Fig. 12C) . Like VGlut1, a second excitatory synapse marker, VGlut2, failed to show any differences in injured M1 cortex (Fig. 12D ). Instead, VGlut2 showed significantly reduced co-localization with homer throughout the brainstem (Fig. 12E) , where it is normally very highly expressed. These results confirm that a significant synaptic re-wiring of the brainstem occurs following spinal cord injury. 
What opportunities for training and professional development has the project provided?
Nothing to Report How were the results disseminated to communities of interest? Nothing to Report What do you plan to do during the next reporting period to accomplish the goals? For the next reporting period, we plan to repeat whether prophylactic gabapentin (GBP) can reduce post-injury synaptogenesis and the frequency of AD.
We will continue the Spinal cord synapse analysis for all experiments (a2d1 vs WT; TSP4 vs WT, GBP vs PBS treatment).
IMPACT What was the impact on the development of the principal disciplines of the project?
Our preliminary study suggested high dose of GBP treatment reduce the frequency of AD after T3 SCI may caused by the increase of inhibitory synapse formation instead of reduce the excitatory synapse which is a novel finding and should be further tested.
What was the impact on other disciplines?
Nothing to report
What was the impact on technology transfer?
What was the impact on society beyond science and technology?
Nothing to report
CHANGES/PROBLEMS Changes in approach and reasons for change
Nothing to report Actual or anticipated problems or delays and actions or plans to resolve them Changes that has a significant impact on expenditures Nothing to report Significant changes in use or care of human subjects, vertebrate animals biohazards, and/or select agents Nothing to report Significant changes in use or care of human subjects NA Significant changes in use or care of vertebrate animals NA Significant changes in use of biohazards and/ or select agents. NA
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